Ownership: Schwab Charles Investment Management Inc., Insys Therapeutics

Schwab Charles Investment Management Inc. is an owner of Insys Therapeutics

Title Investor
Is Current yes
Shares 126 Thousand
Updated about 7 years ago

Source Links